Ghent University Academic Bibliography

Advanced

Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study - Response

JGM KLIJN and Luc Duchateau UGent (2000) JOURNAL OF THE NATIONAL CANCER INSTITUTE. 92(24). p.2041-2042
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle
publication status
published
subject
journal title
JOURNAL OF THE NATIONAL CANCER INSTITUTE
J. Natl. Cancer Inst.
volume
92
issue
24
pages
2041-2042 pages
publisher
NATL CANCER INSTITUTE
Web of Science type
Letter
Web of Science id
000165936800019
ISSN
0027-8874
language
English
UGent publication?
yes
classification
A1
id
346913
handle
http://hdl.handle.net/1854/LU-346913
date created
2006-10-03 09:25:00
date last changed
2008-02-22 22:59:25
@article{346913,
  author       = {KLIJN, JGM and Duchateau, Luc},
  issn         = {0027-8874},
  journal      = {JOURNAL OF THE NATIONAL CANCER INSTITUTE},
  language     = {eng},
  number       = {24},
  pages        = {2041--2042},
  publisher    = {NATL CANCER INSTITUTE},
  title        = {Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study - Response},
  volume       = {92},
  year         = {2000},
}

Chicago
KLIJN, JGM, and Luc Duchateau. 2000. “Re: Combined Treatment with Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study - Response.” Journal of the National Cancer Institute 92 (24): 2041–2042.
APA
KLIJN, J., & Duchateau, L. (2000). Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study - Response. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 92(24), 2041–2042.
Vancouver
1.
KLIJN J, Duchateau L. Re: Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study - Response. JOURNAL OF THE NATIONAL CANCER INSTITUTE. NATL CANCER INSTITUTE; 2000;92(24):2041–2.
MLA
KLIJN, JGM, and Luc Duchateau. “Re: Combined Treatment with Buserelin and Tamoxifen in Premenopausal Metastatic Breast Cancer: a Randomized Study - Response.” JOURNAL OF THE NATIONAL CANCER INSTITUTE 92.24 (2000): 2041–2042. Print.